Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Vanda Pharmaceuticals Inc

+ Add to Watchlist

VNDA:US

10.1000 USD 0.0500 0.49%

As of 17:20:00 ET on 05/28/2015.

Company Profile for Vanda Pharmaceuticals Inc (VNDA)

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.

Contact Information

Vanda Pharmaceuticals Inc

2200 Pennsylvania Avenue NW
Suite 300E
Washington, DC 20037
United States
Phone: 202-734-3400
Fax: 1-301-294-1900

Key Executives for Vanda Pharmaceuticals Inc (VNDA)

Mihael H PolymeropoulosPresident/CEO/Co-FounderJames Patrick Kelly "Jim"Senior VP/CFO/Treasurer/Secy
Paolo BaroldiSenior VP/Chief Medical OfficerTom GibbsSenior VP/Chief Commercial Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil